BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 16973241)

  • 1. Convergence of genes implicated in Alzheimer's disease on the cerebral cholesterol shuttle: APP, cholesterol, lipoproteins, and atherosclerosis.
    Carter CJ
    Neurochem Int; 2007 Jan; 50(1):12-38. PubMed ID: 16973241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between the products of the Herpes simplex genome and Alzheimer's disease susceptibility genes: relevance to pathological-signalling cascades.
    Carter CJ
    Neurochem Int; 2008 May; 52(6):920-34. PubMed ID: 18164103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ApoE: crossroads between Alzheimer's disease and atherosclerosis.
    Stojakovic T; Scharnagl H; März W
    Semin Vasc Med; 2004 Aug; 4(3):279-85. PubMed ID: 15630629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of APP pathway mRNAs and proteins in Alzheimer's disease.
    Matsui T; Ingelsson M; Fukumoto H; Ramasamy K; Kowa H; Frosch MP; Irizarry MC; Hyman BT
    Brain Res; 2007 Aug; 1161():116-23. PubMed ID: 17586478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alzheimer's disease. Present and future role of genetics].
    Roks G
    Tijdschr Gerontol Geriatr; 2003 Feb; 34(1):13-20. PubMed ID: 12629906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APP, APOE, complement receptor 1, clusterin and PICALM and their involvement in the herpes simplex life cycle.
    Carter CJ
    Neurosci Lett; 2010 Oct; 483(2):96-100. PubMed ID: 20674675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LRP1 modulates APP trafficking along early compartments of the secretory pathway.
    Waldron E; Heilig C; Schweitzer A; Nadella N; Jaeger S; Martin AM; Weggen S; Brix K; Pietrzik CU
    Neurobiol Dis; 2008 Aug; 31(2):188-97. PubMed ID: 18559293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional interactions of APP with the apoE receptor family.
    Hoe HS; Rebeck GW
    J Neurochem; 2008 Sep; 106(6):2263-71. PubMed ID: 18554321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association analysis of genes involved in cholesterol metabolism located within the linkage region on chromosome 10 and Alzheimer's disease.
    Riemenschneider M; Mahmoodzadeh S; Eisele T; Klopp N; Schwarz S; Wagenpfeil S; Diehl J; Mueller U; Foerstl H; Illig T; Kurz A
    Neurobiol Aging; 2004; 25(10):1305-8. PubMed ID: 15465627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular basics of Alzheimer's disease].
    Grigorenko AP; Rogaev EI
    Mol Biol (Mosk); 2007; 41(2):331-45. PubMed ID: 17514900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does cholesterol act as a protector of cholinergic projections in Alzheimer's disease?
    Bohr IJ
    Lipids Health Dis; 2005 Jun; 4():13. PubMed ID: 15949039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic study of Sardinian patients with Alzheimer's disease.
    Piscopo P; Manfredi A; Malvezzi-Campeggi L; Crestini A; Spadoni O; Cherchi R; Deiana E; Piras MR; Confaloni A
    Neurosci Lett; 2006 May; 398(1-2):124-8. PubMed ID: 16423463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol in Alzheimer's disease and other amyloidogenic disorders.
    Harris JR; Milton NG
    Subcell Biochem; 2010; 51():47-75. PubMed ID: 20213540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cholesterol and Alzheimer's disease].
    Kálmán J; Janka Z
    Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional role of lipoprotein receptors in Alzheimer's disease.
    Jaeger S; Pietrzik CU
    Curr Alzheimer Res; 2008 Feb; 5(1):15-25. PubMed ID: 18288927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic risk and transcriptional variability of amyloid precursor protein in Alzheimer's disease.
    Brouwers N; Sleegers K; Engelborghs S; Bogaerts V; Serneels S; Kamali K; Corsmit E; De Leenheir E; Martin JJ; De Deyn PP; Van Broeckhoven C; Theuns J
    Brain; 2006 Nov; 129(Pt 11):2984-91. PubMed ID: 16931535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic interaction between tau and the apolipoprotein E receptor LRP1 Increases Alzheimer's disease risk.
    Vázquez-Higuera JL; Mateo I; Sánchez-Juan P; Rodríguez-Rodríguez E; Pozueta A; Infante J; Berciano J; Combarros O
    Dement Geriatr Cogn Disord; 2009; 28(2):116-20. PubMed ID: 19684401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposing effects of Apoe/Apoa1 double deletion on amyloid-β pathology and cognitive performance in APP mice.
    Fitz NF; Tapias V; Cronican AA; Castranio EL; Saleem M; Carter AY; Lefterova M; Lefterov I; Koldamova R
    Brain; 2015 Dec; 138(Pt 12):3699-715. PubMed ID: 26510953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variations in the neuropathology of familial Alzheimer's disease.
    Shepherd C; McCann H; Halliday GM
    Acta Neuropathol; 2009 Jul; 118(1):37-52. PubMed ID: 19306098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.